We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RAONF market cap is 206.64M. The company's latest EPS is AUD -0.0816 and P/E is -14.83.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 256k | 425k | 708k | 3.13M | 4M |
| Operating Income | -3.86M | -6.36M | -11.26M | -10.52M | -14.65M |
| Net Income | -3.85M | -6.34M | -11.2M | -9.92M | -13.82M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 5.93M | 14.25M | 37.53M | 26.64M | 20.23M |
| Total Liabilities | 244k | 524k | 1.42M | 1.15M | 1.92M |
| Total Equity | 5.69M | 13.72M | 36.11M | 25.49M | 18.31M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -2.46M | -4.7M | -6.26M | -10.65M | -9.55M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 3.21M | 12.28M | 30.52M | -1.28M | 5.21M |
| Market Cap | 206.64M |
| Price to Earnings Ratio | -14.83 |
| Price to Sales Ratio | 51.27 |
| Price to Cash Ratio | 11.92 |
| Price to Book Ratio | 11.19 |
| Dividend Yield | - |
| Shares Outstanding | 169.38M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 46.99% |
| 52 Week High | 1.22 |
| 52 Week Low | 0.83 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Race Oncololgy Ltd (PK) |
| Address |
level 36 sydney, new south wales 2000 |
| Website | https://www.raceoncology.com |
| Industry | drug & proprietary stores (5912) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
